Uncategorized
Xen gel stent maintains reduced IOP at 1 year
BARCELONA — Reduced IOP and reduced need for medications was maintained at 1 year after implantation of the Xen gel stent, according to a speaker here. “We like to call the AqueSys Xen gel stent a hybrid system,” Ingeborg Stalmans, MD, PhD, said at the European Society of Cataract and Refractive Surgeons meeting. The ab interno glaucoma device is less invasive than trabeculectomy, but also targets the subconjunctival space as trabeculectomy does.